N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin-Reference-Cited by-同舟云学术

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

Published:2016-11-15 Issue:11 Volume:8 Page:339
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Lenglet Aurélie,Liabeuf Sophie,Bodeau Sandra,Louvet Loïc,Mary Aurélien,Boullier Agnès,Lemaire-Hurtel Anne,Jonet Alexia,Sonnet Pascal,Kamel Said,Massy Ziad

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.mdpi.com/2072-6651/8/11/339/pdf

Reference43 articles.

1. Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine

2. Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure

3. Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat.

4. Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients

5. Review on uremic toxins: Classification, concentration, and interindividual variability

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAD metabolism and heart failure: Mechanisms and therapeutic potentials;Journal of Molecular and Cellular Cardiology;2024-10

2. Regulation of and challenges in targeting NAD+ metabolism;Nature Reviews Molecular Cell Biology;2024-07-18

3. Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations;iScience;2024-07

4. Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions;Metabolites;2024-06-19

5. Metabolite accumulation from oral NMN supplementation drives aging-specific kidney inflammation;2024-04-13